AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$371M
This Quarter Return
+11.04%
1 Year Return
+16.18%
3 Year Return
+64.49%
5 Year Return
+102.68%
10 Year Return
–
AUM
$371M
AUM Growth
+$371M
(-9.1%)
Cap. Flow
-$76.6M
Cap. Flow
% of AUM
-20.65%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
167
New
21
Increased
20
Reduced
78
Closed
48
Top Buys
| 1 |
Aaon
AAON
|
$5.57M |
| 2 |
Privia Health
PRVA
|
$3.94M |
| 3 |
Cadre Holdings
CDRE
|
$3.73M |
| 4 |
EXL Service
EXLS
|
$3.56M |
| 5 |
BCPC
Balchem Corporation
BCPC
|
$3.39M |
Top Sells
| 1 |
Grocery Outlet
GO
|
$6.47M |
| 2 |
FTAI Aviation
FTAI
|
$6.15M |
| 3 |
Agilysys
AGYS
|
$5.51M |
| 4 |
ESCO Technologies
ESE
|
$5.37M |
| 5 |
Sterling Infrastructure
STRL
|
$4.72M |
Sector Composition
| 1 | Industrials | 36.07% |
| 2 | Technology | 22.78% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Healthcare | 10.46% |
| 5 | Materials | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Riot Platforms
RIOT
$5.09B
| $462K | 0.12% | 40,902 -9,736 | -19% | -$110K |
|
102
Collegium Pharmaceutical
COLL
$1.22B
| $459K | 0.12% | 15,531 -3,630 | -19% | -$107K |
|
103
CleanSpark
CLSK
$2.66B
| $405K | 0.11% | 36,753 -8,782 | -19% | -$96.9K |
|
104
MiMedx Group
MDXG
$1.05B
| $403K | 0.11% | 66,124 -15,505 | -19% | -$94.6K |
|
105
Krystal Biotech
KRYS
$4.27B
| $398K | 0.11% | 2,894 -675 | -19% | -$92.8K |
|
106
Protagonist Therapeutics
PTGX
$3.67B
| $385K | 0.1% | 6,972 -1,662 | -19% | -$91.9K |
|
107
Catalyst Pharmaceutical
CPRX
$2.52B
| $352K | 0.09% | 16,200 -3,837 | -19% | -$83.3K |
|
108
Castle Biosciences
CSTL
$696M
| $327K | 0.09% | 16,021 -3,784 | -19% | -$77.3K |
|
109
Dynavax Technologies
DVAX
$1.19B
| $309K | 0.08% | 31,158 -7,285 | -19% | -$72.3K |
|
110
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $305K | 0.08% | 11,020 -2,577 | -19% | -$71.3K |
|
111
Acadia Pharmaceuticals
ACAD
$4.38B
| $273K | 0.07% | 12,643 -2,958 | -19% | -$63.8K |
|
112
Marathon Digital Holdings
MARA
$5.92B
| $236K | 0.06% | 15,069 -3,632 | -19% | -$57K |
|
113
Interparfums
IPAR
$3.69B
| $208K | 0.06% | +1,584 | New | +$208K |
|
114
Ligand Pharmaceuticals
LGND
$3.15B
| $207K | 0.06% | +1,823 | New | +$207K |
|
115
Arrowhead Research
ARWR
$3.05B
| $204K | 0.06% | +12,938 | New | +$204K |
|
116
Aurinia Pharmaceuticals
AUPH
$1.58B
| $204K | 0.06% | +24,079 | New | +$204K |
|
117
PTC Therapeutics
PTCT
$3.92B
| $204K | 0.06% | +4,174 | New | +$204K |
|
118
Stoke Therapeutics
STOK
$1.08B
| $203K | 0.05% | +17,888 | New | +$203K |
|
119
Amicus Therapeutics
FOLD
$2.34B
| $201K | 0.05% | +35,082 | New | +$201K |
|
120
MannKind Corp
MNKD
$1.41B
| – | – | -45,394 | Closed | -$228K |
|
121
Ameris Bancorp
ABCB
$5.03B
| – | – | -3,792 | Closed | -$218K |
|
122
Associated Banc-Corp
ASB
$4.47B
| – | – | -9,523 | Closed | -$215K |
|
123
Axos Financial
AX
$5.15B
| – | – | -3,321 | Closed | -$214K |
|
|
AZEK
124
DELISTED
The AZEK Co
AZEK
| – | – | -36,266 | Closed | -$1.77M |
|
125
BancFirst
BANF
$4.43B
| – | – | -2,279 | Closed | -$250K |
|